Compared with vehicle control-treated CCA cells, the protein expression of PTEN was increased by 2-fold and the phosphorylation of AKT was reduced by 65%, respectively, in CCA cell treatment with galangin (Figure 5(a)). The gene discussed is AKT1; the disease is cholangiocarcinoma.